- Home
- MLGO vs PLRX Comparison
MLGO vs PLRX Comparison
Compare MLGO & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLGO
- PLRX
- Stock Information
- Founded
- MLGO 2018
- PLRX 2015
- Country
- MLGO China
- PLRX United States
- Employees
- MLGO 87
- PLRX N/A
- Industry
- MLGO EDP Services
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- MLGO Technology
- PLRX Health Care
- Exchange
- MLGO Nasdaq
- PLRX Nasdaq
- Market Cap
- MLGO 101.1M
- PLRX 104.4M
- IPO Year
- MLGO N/A
- PLRX 2020
- Fundamental
- Price
- MLGO $9.06
- PLRX $1.66
- Analyst Decision
- MLGO
- PLRX Hold
- Analyst Count
- MLGO 0
- PLRX 10
- Target Price
- MLGO N/A
- PLRX $9.79
- AVG Volume (30 Days)
- MLGO 675.5K
- PLRX 1.0M
- Earning Date
- MLGO 09-18-2025
- PLRX 08-15-2025
- Dividend Yield
- MLGO N/A
- PLRX N/A
- EPS Growth
- MLGO N/A
- PLRX N/A
- EPS
- MLGO 16.40
- PLRX N/A
- Revenue
- MLGO $74,185,505.00
- PLRX N/A
- Revenue This Year
- MLGO N/A
- PLRX N/A
- Revenue Next Year
- MLGO N/A
- PLRX N/A
- P/E Ratio
- MLGO $0.56
- PLRX N/A
- Revenue Growth
- MLGO N/A
- PLRX N/A
- 52 Week Low
- MLGO $8.52
- PLRX $1.10
- 52 Week High
- MLGO $972.00
- PLRX $16.10
- Technical
- Relative Strength Index (RSI)
- MLGO 29.32
- PLRX 52.17
- Support Level
- MLGO $8.80
- PLRX $1.60
- Resistance Level
- MLGO $10.60
- PLRX $1.75
- Average True Range (ATR)
- MLGO 1.04
- PLRX 0.12
- MACD
- MLGO 0.93
- PLRX 0.01
- Stochastic Oscillator
- MLGO 5.74
- PLRX 31.43
About MLGO MicroAlgo Inc.
MicroAlgo Inc is divided into two segments: Central processing algorithm services & Intelligent chips and services. The majority is from the Central Processing Algorithm Services. which refers to a range of computing algorithms, analytical algorithms, recommendation algorithms, & acceleration algorithms. The businesses engaged in internet advertisement, game development, intelligent chip design, finance, retail, & logistics depend on the ability to process & analyze data with optimized computing software & hardware capable of handling the data workload. Intelligent chips and services revenues include revenues generated from the resale of intelligent chips. All of the Company's net revenues were generated in the PRC, Hong Kong, & Singapore, out of which the majority is from the PRC.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.